Cash flow
Novatti’s cashflow continued to strengthen over the FY20 year. Product manufacturing and
operating costs as a percentage of receipts from customers reduced from 75.9% in FY19 to
68.5% in FY20, reflecting the lower direct costs to deliver its increased processing revenue.
Novatti was almost cashflow positive as net cash used in operations for the quarter narrowed
to just $16,000, down from $543,000 in the March 2020 quarter.
While Novatti held $2.6 million in cash at the end of the June quarter, this does not include
the $10.2 million raised through a share placement announced at the end of the quarter.
Going forward, Novatti’s management will continue to prudently balance cashflow to
navigate the challenges of COVID-19 while pursuing its growth strategy.
Revenue
Despite the widespread disruption caused by COVID-19 during the June quarter, Novatti
maintained record operating revenue of $3.05 million (unaudited), slightly higher than its
March 2020 quarter result.
This result furthers Novatti’s record of delivering consistent, long-term revenue growth with
the FY20 total revenue increasing more than 33 per cent on the previous financial year's
$8.9m to $11.86 million (unaudited).
- Forums
- ASX - By Stock
- NOV
- Ann: Corporate Presentation
Ann: Corporate Presentation, page-148
Featured News
Add NOV (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.1¢ |
Change
0.001(2.00%) |
Mkt cap ! $17.75M |
Open | High | Low | Value | Volume |
5.1¢ | 5.1¢ | 5.1¢ | $3.009K | 59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 48301 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.050 |
2 | 40408 | 0.049 |
3 | 269333 | 0.048 |
1 | 112713 | 0.047 |
1 | 16055 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 48301 | 1 |
0.054 | 100000 | 1 |
0.055 | 82135 | 2 |
0.056 | 51783 | 1 |
0.057 | 10000 | 1 |
Last trade - 10.06am 02/05/2024 (20 minute delay) ? |
Featured News
NOV (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, MD & Executive Chairman
David Breeze
MD & Executive Chairman
SPONSORED BY The Market Online